$DNMR
Danimer Scientific, Inc.

2022 Q4 Form 10-Q Financial Statement

#000095017022023316 Filed on November 08, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3
Revenue $15.32M $10.45M
YoY Change -13.56% -21.85%
Cost Of Revenue $21.11M $14.50M
YoY Change 8.25% 6.63%
Gross Profit -$5.783M -$4.055M
YoY Change 226.72% 1647.84%
Gross Profit Margin -37.74% -38.81%
Selling, General & Admin $17.64M $19.41M
YoY Change -28.04% -27.0%
% of Gross Profit
Research & Development $3.553M $7.947M
YoY Change -48.54% 58.62%
% of Gross Profit
Depreciation & Amortization $7.281M $4.584M
YoY Change 73.98% 44.24%
% of Gross Profit
Operating Expenses $23.94M $27.36M
YoY Change -28.46% -13.42%
Operating Profit -$29.72M -$94.91M
YoY Change -15.64% 198.13%
Interest Expense $1.226M $553.0K
YoY Change -94.23% 124.8%
% of Operating Profit
Other Income/Expense, Net $399.0K -$206.0K
YoY Change -286.45% -100.73%
Pretax Income -$28.09M -$95.11M
YoY Change 97.07% 2543.47%
Income Tax -$43.00K -$236.0K
% Of Pretax Income
Net Earnings -$28.05M -$94.88M
YoY Change 125.38% -1312.47%
Net Earnings / Revenue -183.05% -908.08%
Basic Earnings Per Share -$0.94
Diluted Earnings Per Share -$0.28 -$937.5K
COMMON SHARES
Basic Shares Outstanding 101.4M 101.2M
Diluted Shares Outstanding 101.2M

Balance Sheet

Concept 2022 Q4 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $62.79M $99.13M
YoY Change -78.08% -48.96%
Cash & Equivalents $62.79M $99.13M
Short-Term Investments
Other Short-Term Assets $5.225M $5.080M
YoY Change 10.3% 42.98%
Inventory $32.74M $35.20M
Prepaid Expenses $5.225M $5.080M
Receivables $17.99M $17.43M
Other Receivables $1.635M $1.377M
Total Short-Term Assets $125.1M $162.6M
YoY Change -63.25% -31.93%
LONG-TERM ASSETS
Property, Plant & Equipment $453.9M $436.9M
YoY Change 43.57% 96.32%
Goodwill $0.00 $0.00
YoY Change -100.0% -100.0%
Intangibles $80.94M $81.49M
YoY Change -4.39% -5.97%
Long-Term Investments
YoY Change
Other Assets $226.0K $227.0K
YoY Change 0.89% 55.48%
Total Long-Term Assets $587.2M $570.8M
YoY Change 17.85% 38.75%
TOTAL ASSETS
Total Short-Term Assets $125.1M $162.6M
Total Long-Term Assets $587.2M $570.8M
Total Assets $712.3M $733.4M
YoY Change -15.06% 12.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $14.98M $4.324M
YoY Change -27.96% -78.78%
Accrued Expenses $5.001M $20.41M
YoY Change -73.37% 138.37%
Deferred Revenue $0.00 $2.000M
YoY Change -100.0% 758.37%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.972M $1.501M
YoY Change 452.38% 349.4%
Total Short-Term Liabilities $25.29M $31.57M
YoY Change -41.84% -2.73%
LONG-TERM LIABILITIES
Long-Term Debt $286.4M $286.0M
YoY Change 9.76% 868.2%
Other Long-Term Liabilities $447.0K $641.0K
YoY Change -29.94% -40.21%
Total Long-Term Liabilities $447.0K $641.0K
YoY Change -29.94% -97.91%
TOTAL LIABILITIES
Total Short-Term Liabilities $25.29M $31.57M
Total Long-Term Liabilities $447.0K $641.0K
Total Liabilities $334.7M $341.7M
YoY Change -1.09% 181.98%
SHAREHOLDERS EQUITY
Retained Earnings -$298.6M -$270.6M
YoY Change 151.2% 154.22%
Common Stock $10.00K $10.00K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $377.6M $391.7M
YoY Change
Total Liabilities & Shareholders Equity $712.3M $733.4M
YoY Change -15.06% 12.78%

Cashflow Statement

Concept 2022 Q4 2022 Q3
OPERATING ACTIVITIES
Net Income -$28.05M -$94.88M
YoY Change 125.38% -1312.47%
Depreciation, Depletion And Amortization $7.281M $4.584M
YoY Change 73.98% 44.24%
Cash From Operating Activities -$4.255M -$20.19M
YoY Change -72.59% -18.59%
INVESTING ACTIVITIES
Capital Expenditures $30.85M -$24.78M
YoY Change -134.82% -44.8%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$18.04M
YoY Change -100.0% -88.07%
Cash From Investing Activities -$30.85M -$42.82M
YoY Change -65.15% -78.16%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.280M 22.96M
YoY Change -100.66% 7844.98%
NET CHANGE
Cash From Operating Activities -4.255M -20.19M
Cash From Investing Activities -30.85M -42.82M
Cash From Financing Activities -1.280M 22.96M
Net Change In Cash -36.39M -40.05M
YoY Change -140.13% -81.84%
FREE CASH FLOW
Cash From Operating Activities -$4.255M -$20.19M
Capital Expenditures $30.85M -$24.78M
Free Cash Flow -$35.11M $4.593M
YoY Change -148.03% -77.14%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Goodwill
Goodwill
62649000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
19083000
us-gaap Business Combination Provisional Information Initial Accounting Incomplete Adjustment Property Plant And Equipment
BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Amendment Flag
AmendmentFlag
false
dnmr Business Combination Provisional Information Initial Accounting Incomplete Adjustment Contingent Purchase Price Payable
BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentContingentPurchasePricePayable
dnmr Business Combination Provisional Information Initial Accounting Incomplete Adjustment Other Assets Acquired
BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsAcquired
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001779020
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
1194000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
19240000
CY2022Q3 dnmr Leverage Loans Receivable
LeverageLoansReceivable
31446000
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
2019000
dnmr Business Combination Provisional Information Initial Accounting Incomplete Adjustments Deferred Tax Liability
BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsDeferredTaxLiability
dnmr Inventory Consumed In Constructing Property Plant And Equipment
InventoryConsumedInConstructingPropertyPlantAndEquipment
dnmr Business Combination Provisional Information Initial Accounting Incomplete Adjustment Right Of Use Assets Acquired
BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRightOfUseAssetsAcquired
dnmr Business Combination Provisional Information Initial Accounting Incomplete Adjustment Cash And Restricted Cash
BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndRestrictedCash
us-gaap Business Combination Provisional Information Initial Accounting Incomplete Adjustments Related To Previous Period
BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
1578000
dnmr Business Combination Provisional Information Initial Accounting Incomplete Adjustment Lease Liability
BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLeaseLiability
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
5000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-40000
us-gaap Business Combination Provisional Information Initial Accounting Incomplete Adjustment Intangibles
BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39280
dei Entity Registrant Name
EntityRegistrantName
DANIMER SCIENTIFIC, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-1924518
dei Entity Address Address Line1
EntityAddressAddressLine1
140 Industrial Boulevard
dei Entity Address City Or Town
EntityAddressCityOrTown
Bainbridge
dei Entity Address State Or Province
EntityAddressStateOrProvince
GA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
39817
dei City Area Code
CityAreaCode
229
dei Local Phone Number
LocalPhoneNumber
243-7075
dei Security12b Title
Security12bTitle
Class A Common stock, $0.0001 par value per share
dei Trading Symbol
TradingSymbol
DNMR
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
true
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
101388673
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
99127000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
286487000
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
17426000
CY2021Q4 dnmr Leverage Loans Receivable
LeverageLoansReceivable
13408000
CY2022Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1663000
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
481000
CY2021Q4 dnmr Loan Fees
LoanFees
1397000
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
227000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
224000
CY2022Q3 us-gaap Assets
Assets
733375000
CY2021Q4 us-gaap Assets
Assets
838597000
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
4324000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
20790000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
20407000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
18777000
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2000000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
214000
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3337000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3337000
CY2022Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
1501000
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
357000
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
31569000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
43475000
CY2022Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
964000
CY2021Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
9578000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
22265000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
22693000
CY2022Q3 us-gaap Other Long Term Debt
OtherLongTermDebt
285969000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-4642000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
887000
CY2021Q4 us-gaap Other Long Term Debt
OtherLongTermDebt
260934000
CY2022Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
246000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-5035000
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1014000
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
641000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
638000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-4338000
CY2022Q3 us-gaap Liabilities
Liabilities
341654000
CY2021Q4 us-gaap Liabilities
Liabilities
338332000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
1786000
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
101388673
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
101388673
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
100687820
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
100687820
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
10000
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
662308000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
619145000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-270597000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-118890000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
391721000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
500265000
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
733375000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
838597000
CY2022Q3 us-gaap Revenues
Revenues
10448000
CY2021Q3 us-gaap Revenues
Revenues
13369000
us-gaap Revenues
Revenues
37894000
us-gaap Revenues
Revenues
41021000
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
14503000
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
13601000
us-gaap Cost Of Revenue
CostOfRevenue
45606000
us-gaap Cost Of Revenue
CostOfRevenue
37786000
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
19413000
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
26592000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
62042000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
55791000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7947000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5010000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
24469000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11604000
CY2022Q3 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
0
CY2021Q3 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
0
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
-1000
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
-33000
CY2022Q3 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
63491000
CY2021Q3 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
63491000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
105354000
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
45203000
us-gaap Costs And Expenses
CostsAndExpenses
195609000
us-gaap Costs And Expenses
CostsAndExpenses
105214000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-94906000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-31834000
us-gaap Operating Income Loss
OperatingIncomeLoss
-157715000
us-gaap Operating Income Loss
OperatingIncomeLoss
-64193000
CY2022Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1607000
CY2021Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-28392000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-8614000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-6435000
CY2022Q3 us-gaap Interest Expense
InterestExpense
553000
CY2021Q3 us-gaap Interest Expense
InterestExpense
164000
us-gaap Interest Expense
InterestExpense
2197000
us-gaap Interest Expense
InterestExpense
516000
CY2022Q3 dnmr Gain Loss On Forgiveness Of Debt
GainLossOnForgivenessOfDebt
0
CY2021Q3 dnmr Gain Loss On Forgiveness Of Debt
GainLossOnForgivenessOfDebt
0
dnmr Gain Loss On Forgiveness Of Debt
GainLossOnForgivenessOfDebt
0
dnmr Gain Loss On Forgiveness Of Debt
GainLossOnForgivenessOfDebt
1776000
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1500000
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1500000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-152474000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-59084000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-236000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-11423000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-767000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-11423000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-94876000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
7825000
us-gaap Net Income Loss
NetIncomeLoss
-151707000
us-gaap Net Income Loss
NetIncomeLoss
-47661000
CY2022Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.94
CY2021Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.08
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-1.50
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.53
CY2022Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.94
CY2021Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.08
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-1.50
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.53
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-2221000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-57582000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-47441000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
101199195
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
98160626
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
100993068
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
90614910
CY2021Q3 dnmr Dilutive Effect Of Warrants And Stock Options
DilutiveEffectOfWarrantsAndStockOptions
5360126
dnmr Dilutive Effect Of Warrants And Stock Options
DilutiveEffectOfWarrantsAndStockOptions
0
dnmr Dilutive Effect Of Warrants And Stock Options
DilutiveEffectOfWarrantsAndStockOptions
0
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
90614910
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
391721000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
529079000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
391721000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
529079000
us-gaap Profit Loss
ProfitLoss
-151707000
us-gaap Profit Loss
ProfitLoss
-47661000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-8614000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-6435000
us-gaap Share Based Compensation
ShareBasedCompensation
42398000
us-gaap Share Based Compensation
ShareBasedCompensation
35093000
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
13172000
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
7489000
dnmr Inventory Reserves
InventoryReserves
609000
dnmr Inventory Reserves
InventoryReserves
0
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-767000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-11423000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1601000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
337000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
17149000
CY2022Q3 us-gaap Other Receivables
OtherReceivables
1377000
CY2021Q4 us-gaap Other Receivables
OtherReceivables
3836000
CY2022Q3 us-gaap Inventory Net
InventoryNet
35201000
CY2021Q4 us-gaap Inventory Net
InventoryNet
24573000
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5080000
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4737000
CY2022Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
4379000
CY2021Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
3576000
CY2022Q3 us-gaap Assets Current
AssetsCurrent
162590000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
340358000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
436875000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
316181000
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
81491000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
84659000
dnmr Gain Loss On Forgiveness Of Debt
GainLossOnForgivenessOfDebt
0
CY2022Q3 us-gaap Goodwill
Goodwill
0
dnmr Gain Loss On Forgiveness Of Debt
GainLossOnForgivenessOfDebt
1776000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-2604000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
240000
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
10000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
8000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
324000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
18000
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-206000
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
28236000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5241000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5109000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-95112000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3598000
dnmr Amortization Of Right Of Use Assets And Lease Liability
AmortizationOfRightOfUseAssetsAndLeaseLiability
-270000
dnmr Amortization Of Right Of Use Assets And Lease Liability
AmortizationOfRightOfUseAssetsAndLeaseLiability
-942000
dnmr Contract With Customer Asset Reserves Recorded
ContractWithCustomerAssetReservesRecorded
-1216000
dnmr Contract With Customer Asset Reserves Recorded
ContractWithCustomerAssetReservesRecorded
0
dnmr Loss On Extinguishment Of Debt
LossOnExtinguishmentOfDebt
1500000
CY2022Q3 dnmr Dilutive Effect Of Warrants And Stock Options
DilutiveEffectOfWarrantsAndStockOptions
0
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
101199195
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
103520752
dnmr Loss On Extinguishment Of Debt
LossOnExtinguishmentOfDebt
1900000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
63491000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
100993068
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1249000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-186000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1747000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6331000
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-2724000
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
3000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
100790000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
196297000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
14271000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
9471000
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-1749000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
133632000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
96798000
us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
18037000
us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
0
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
14000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
151179000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
55000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
340000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-151628000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-247637000
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
0
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
138196000
us-gaap Proceeds From Repayments Of Other Long Term Debt
ProceedsFromRepaymentsOfOtherLongTermDebt
24700000
us-gaap Proceeds From Repayments Of Other Long Term Debt
ProceedsFromRepaymentsOfOtherLongTermDebt
169000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1547000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1691000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
215000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2676000
dnmr Proceeds From Employee Stock Purchase Plan
ProceedsFromEmployeeStockPurchasePlan
526000
dnmr Proceeds From Employee Stock Purchase Plan
ProceedsFromEmployeeStockPurchasePlan
106000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
886000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
27086000
dnmr Payments Related To Warrants Costs
PaymentsRelatedToWarrantsCosts
55000
dnmr Payments Related To Warrants Costs
PaymentsRelatedToWarrantsCosts
0
dnmr Proceeds Costs From Issuance Of Common Stock Net Of Issuance Costs
ProceedsCostsFromIssuanceOfCommonStockNetOfIssuanceCosts
79000
dnmr Proceeds Costs From Issuance Of Common Stock Net Of Issuance Costs
ProceedsCostsFromIssuanceOfCommonStockNetOfIssuanceCosts
-892000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
23032000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
111478000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-186178000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-183600000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
286968000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
379897000
CY2021Q4 dnmr Intangible Assets Not Yet Amortized
IntangibleAssetsNotYetAmortized
869000
CY2021Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
2741000
CY2022Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
2741000
CY2021Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
18622000
CY2022Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
18622000
CY2021Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Other
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
2302000
CY2022Q3 dnmr Amortization Intangible Assets Gross
AmortizationIntangibleAssetsGross
92544000
CY2022Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Other
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
2302000
CY2021Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Other Noncurrent Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
2715000
CY2022Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Other Noncurrent Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
2715000
CY2021Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
84400000
CY2022Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
84400000
CY2021Q4 dnmr Acquired Goodwill
AcquiredGoodwill
62649000
dnmr Business Combination Provisional Information Initial Accounting Incomplete Adjustment Goodwill
BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill
14000
CY2022Q3 dnmr Acquired Goodwill
AcquiredGoodwill
62663000
CY2021Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
14246000
CY2021Q4 dnmr Amortization Intangible Assets Gross
AmortizationIntangibleAssetsGross
92375000
CY2022Q3 dnmr Amortization Intangible Assets Net
AmortizationIntangibleAssetsNet
80407000
CY2021Q4 dnmr Amortization Intangible Assets Net
AmortizationIntangibleAssetsNet
83790000
CY2022Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
14246000
CY2021Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Financial Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities
-2759000
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
81491000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
84659000
dnmr Interim Quantitative Impairment Assessment Control Premium Percentage
InterimQuantitativeImpairmentAssessmentControlPremiumPercentage
0.10
CY2022Q3 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
2100000
CY2021Q3 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
100000
CY2021Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
1250000
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
5700000
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
300000
CY2022Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Financial Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities
-2759000
CY2021Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
2004000
dnmr Business Combination Provisional Information Initial Accounting Incomplete Adjustment Liabilities Assumed
BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed
-14000
CY2022Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
2018000
CY2021Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Contingent Liability
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability
-500000
CY2022Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Contingent Liability
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability
-500000
CY2021Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
153920000
CY2022Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
153920000
CY2022Q3 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
10448000
CY2021Q3 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
13369000
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
37894000
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
41021000
CY2022Q3 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-94906000
CY2021Q3 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-33225000
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-157715000
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-73418000
CY2022Q3 us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
2800000
us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
8600000
CY2022Q3 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
144000000
CY2022Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.50
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
62700000
CY2022Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.28
us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P18Y9M18D
CY2022Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
18973000
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
11555000
CY2022Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
1527000
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
928000
CY2022Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
14701000
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
12090000
CY2022Q3 us-gaap Inventory Net
InventoryNet
35201000
CY2021Q4 us-gaap Inventory Net
InventoryNet
24573000
CY2022Q3 dnmr Finished Neat Pha Included In Finished Goods
FinishedNeatPhaIncludedInFinishedGoods
5700000
CY2021Q4 dnmr Finished Neat Pha Included In Finished Goods
FinishedNeatPhaIncludedInFinishedGoods
5600000
CY2022Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
600000
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
475671000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
345363000
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
38796000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
29182000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
436875000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
316181000
CY2022Q3 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
4585000
CY2021Q3 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
3179000
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
13172000
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
7489000
CY2022Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
291960000
CY2021Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
212647000
CY2022Q3 us-gaap Accumulated Capitalized Interest Costs
AccumulatedCapitalizedInterestCosts
11400000
CY2021Q4 us-gaap Accumulated Capitalized Interest Costs
AccumulatedCapitalizedInterestCosts
5700000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
18777000
CY2022Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
93628000
CY2021Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
93244000
CY2022Q3 dnmr Intangible Assets Not Yet Amortized
IntangibleAssetsNotYetAmortized
1084000
CY2021Q4 us-gaap Goodwill
Goodwill
62649000
dnmr Business Combination Provisional Information Initial Accounting Incomplete Adjustment Goodwill
BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill
14000
CY2022Q3 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
62663000
CY2022Q3 us-gaap Goodwill
Goodwill
0
CY2022Q3 dnmr Construction In Progress Accrued Liabilities
ConstructionInProgressAccruedLiabilities
13219000
CY2021Q4 dnmr Construction In Progress Accrued Liabilities
ConstructionInProgressAccruedLiabilities
8896000
CY2022Q3 us-gaap Interest Payable Current
InterestPayableCurrent
2377000
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
274000
CY2022Q3 dnmr Accrued Compensation And Related Liabilities
AccruedCompensationAndRelatedLiabilities
1118000
CY2021Q4 dnmr Accrued Compensation And Related Liabilities
AccruedCompensationAndRelatedLiabilities
4572000
CY2022Q3 dnmr Other Accrued Taxes
OtherAccruedTaxes
852000
CY2021Q4 dnmr Other Accrued Taxes
OtherAccruedTaxes
500000
CY2022Q3 dnmr Loss On Supply Contract Accrued Liabilities
LossOnSupplyContractAccruedLiabilities
689000
CY2021Q4 dnmr Loss On Supply Contract Accrued Liabilities
LossOnSupplyContractAccruedLiabilities
1423000
CY2022Q3 us-gaap Accrued Utilities Current And Noncurrent
AccruedUtilitiesCurrentAndNoncurrent
639000
CY2021Q4 us-gaap Accrued Utilities Current And Noncurrent
AccruedUtilitiesCurrentAndNoncurrent
320000
CY2022Q3 dnmr Transaction Costs And Other Legal Fees
TransactionCostsAndOtherLegalFees
504000
CY2021Q4 dnmr Transaction Costs And Other Legal Fees
TransactionCostsAndOtherLegalFees
850000
CY2022Q3 dnmr Accrued Legal Settlement Liabilities
AccruedLegalSettlementLiabilities
313000
CY2021Q4 dnmr Accrued Legal Settlement Liabilities
AccruedLegalSettlementLiabilities
1250000
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
696000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
692000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
20407000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
18300000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
11439142
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
14.05
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y1M17D
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
5637529000
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
14305000
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
15158000
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
146666
CY2022Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.04
CY2021Q4 dnmr Long Term Debt Net Of Current Maturities And Debt Issuance Costs
LongTermDebtNetOfCurrentMaturitiesAndDebtIssuanceCosts
260934000
CY2021Q4 dnmr Convertible Senior Notes Due Year
ConvertibleSeniorNotesDueYear
2026
CY2022Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-200000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-800000
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.002
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.005
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
3.175
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.193
CY2022Q3 dnmr Operating Lease Expense Benefit Net
OperatingLeaseExpenseBenefitNet
875000
CY2021Q3 dnmr Operating Lease Expense Benefit Net
OperatingLeaseExpenseBenefitNet
780000
dnmr Operating Lease Expense Benefit Net
OperatingLeaseExpenseBenefitNet
2636000
dnmr Operating Lease Expense Benefit Net
OperatingLeaseExpenseBenefitNet
1643000
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3914525
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3914525
us-gaap Class Of Warrant Or Righst Date From Which Warrants Or Rights Exercisable
ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable
2021-05-07
dnmr Summary Of Rollforward Of Private Warrants Liability
SummaryOfRollforwardOfPrivateWarrantsLiability
<span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A roll-forward of the Private Warrants liability is below.</span> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:62.699%;"/> <td style="width:2.44%;"/> <td style="width:17.301%;"/> <td style="width:2.839%;"/> <td style="width:1.0%;"/> <td style="width:12.722000000000001%;"/> <td style="width:1.0%;"/> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(in thousands)</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance at December 31, 2021</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,578</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gain on remeasurement of private warrants</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,995</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance at March 31, 2022</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,583</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gain on remeasurement of private warrants</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,012</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance at June 30, 2022</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,571</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gain on remeasurement of private warrants</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,607</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance at September 30, 2022</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:right;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">964</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td> </tr> </table>
CY2022Q3 us-gaap Long Term Debt
LongTermDebt
297875000
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
271854000
CY2022Q3 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
10405000
CY2021Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
10563000
CY2022Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
1501000
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
357000
CY2022Q3 dnmr Long Term Debt Net Of Current Maturities And Debt Issuance Costs
LongTermDebtNetOfCurrentMaturitiesAndDebtIssuanceCosts
285969000
CY2021Q4 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
10.79
CY2022Q3 dnmr Additional Principal Amount
AdditionalPrincipalAmount
24700000
CY2022Q3 dnmr Leverage Loans Receivable
LeverageLoansReceivable
31400000
CY2021Q4 dnmr Leverage Loans Receivable
LeverageLoansReceivable
13400000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
42550000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
35853000
CY2022Q1 dnmr Restricted Stock Shares
RestrictedStockShares
103092
CY2021Q1 dnmr Additional Restricted Stock Shares Granted
AdditionalRestrictedStockSharesGranted
1517840
CY2022Q3 dnmr Performance Stock Shares Issued
PerformanceStockSharesIssued
0
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10589010
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
101114861
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
97732079
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
100687820
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
84535640
CY2022Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
273812
CY2021Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
2592236
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
700853
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
15788675
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
101388673
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
100324315
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
101388673
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
100324315
CY2021Q2 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
138100000
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
40889142
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8554149
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
40889142
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
17717951
CY2022Q3 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
100000
CY2021Q3 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
200000
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
400000
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
500000
CY2022Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
3200000
CY2021Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
2500000
dnmr Contract With Customer Asset Reserves Recorded
ContractWithCustomerAssetReservesRecorded
-1200000
CY2022Q3 us-gaap Revenues
Revenues
10448000
CY2021Q3 us-gaap Revenues
Revenues
13369000
us-gaap Revenues
Revenues
37894000
us-gaap Revenues
Revenues
41021000
CY2022Q3 dnmr Share Based Compensation Arrangement By Share Based Payment Award Additional Authorized Shares Pool
ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalAuthorizedSharesPool
289951
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
14.85
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y4M20D
CY2022Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
50000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
22473835000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
11227250
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
20711
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.28
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
81300000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
688240
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.96
CY2022Q3 dnmr Number Of Shares Transferred From Liability Based Awards
NumberOfSharesTransferredFromLiabilityBasedAwards
312258
us-gaap Payments For Royalties
PaymentsForRoyalties
300000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
14.24
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y3M25D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
11642645000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
221892
CY2022Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.07
CY2022Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
10000
CY2022Q3 dnmr Weighted Average Exercise Price Transferred From Liability Based Awards
WeightedAverageExercisePriceTransferredFromLiabilityBasedAwards
2.68
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
11877355
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
14.21
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y11M19D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
4473003
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
4.84
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y6M7D
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0
CY2022Q3 dnmr Share Based Compensation Arrangement By Share Based Payment Award Options Vested Number Of Shares Vested And Expected To Vest
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedNumberOfSharesVestedAndExpectedToVest
11877355
CY2022Q3 dnmr Weighted Average Exercise Price Vested And Expected To Vest
WeightedAverageExercisePriceVestedAndExpectedToVest
14.21
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y11M19D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
0
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
1.97
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
7.15
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
146666
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
283396
CY2022Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
74200000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y3M18D
dnmr Cash Paid For Interest Net Of Interest Capitalized
CashPaidForInterestNetOfInterestCapitalized
0
dnmr Cash Paid For Interest Net Of Interest Capitalized
CashPaidForInterestNetOfInterestCapitalized
375000
dnmr Cash Paid For Operating Leases
CashPaidForOperatingLeases
2657000
dnmr Cash Paid For Operating Leases
CashPaidForOperatingLeases
2380000
dnmr Inventory Consumed In Constructing Property Plant And Equipment
InventoryConsumedInConstructingPropertyPlantAndEquipment
3034000
dnmr Changes In Accounts Payable And Accrued Liabilities Related To Purchase Of Property Plant And Equipment
ChangesInAccountsPayableAndAccruedLiabilitiesRelatedToPurchaseOfPropertyPlantAndEquipment
-5157000
dnmr Changes In Accounts Payable And Accrued Liabilities Related To Purchase Of Property Plant And Equipment
ChangesInAccountsPayableAndAccruedLiabilitiesRelatedToPurchaseOfPropertyPlantAndEquipment
9880000
dnmr Royalty Per Share
RoyaltyPerShare
0.05
dnmr Weights Of Pha Sold
WeightsOfPhaSold
500000000
dnmr Decrease Royalty Per Share
DecreaseRoyaltyPerShare
0.025
us-gaap Payments For Royalties
PaymentsForRoyalties
200000
CY2022Q3 dnmr Anticipated Construction
AnticipatedConstruction
62500000
CY2020Q3 dnmr Amount Paid To Resolve Outstanding Claims
AmountPaidToResolveOutstandingClaims
8000000
CY2022Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
300000

Files In Submission

Name View Source Status
0000950170-22-023316-index-headers.html Edgar Link pending
0000950170-22-023316-index.html Edgar Link pending
0000950170-22-023316.txt Edgar Link pending
0000950170-22-023316-xbrl.zip Edgar Link pending
dnmr-20220930.htm Edgar Link pending
dnmr-20220930.xsd Edgar Link pending
dnmr-ex31_1.htm Edgar Link pending
dnmr-ex31_2.htm Edgar Link pending
dnmr-ex32_1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
dnmr-20220930_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
dnmr-20220930_pre.xml Edgar Link unprocessable
dnmr-20220930_def.xml Edgar Link unprocessable
dnmr-20220930_htm.xml Edgar Link completed
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
dnmr-20220930_cal.xml Edgar Link unprocessable